These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33033779)
1. Pregabalin-associated movement disorders: A literature review. Rissardo JP; Caprara ALF Brain Circ; 2020; 6(2):96-106. PubMed ID: 33033779 [TBL] [Abstract][Full Text] [Related]
2. Mirtazapine-associated movement disorders: A literature review. Rissardo JP; Caprara ALF Tzu Chi Med J; 2020; 32(4):318-330. PubMed ID: 33163376 [TBL] [Abstract][Full Text] [Related]
3. Gabapentin-Associated Movement Disorders: A Literature Review. Rissardo JP; Medeiros Araujo de Matos U; Fornari Caprara AL Medicines (Basel); 2023 Sep; 10(9):. PubMed ID: 37755242 [TBL] [Abstract][Full Text] [Related]
4. Buspirone-associated Movement Disorder: A Literature Review. Rissardo JP; Caprara ALF Prague Med Rep; 2020; 121(1):5-24. PubMed ID: 32191616 [TBL] [Abstract][Full Text] [Related]
5. Lamotrigine-Associated Movement Disorder: A Literature Review. Rissardo JP; Fornari Caprara AL Neurol India; 2021; 69(6):1524-1538. PubMed ID: 34979637 [TBL] [Abstract][Full Text] [Related]
6. Lithium-associated movement disorder: A literature review. Rissardo JP; Caprara ALF; Durante Í; Rauber A Brain Circ; 2022; 8(2):76-86. PubMed ID: 35909709 [TBL] [Abstract][Full Text] [Related]
7. Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review. Rissardo JP; Caprara ALF Clin Neuropharmacol; 2020; 43(3):66-80. PubMed ID: 32384309 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone-Associated Movement Disorder: A Literature Review. Rissardo JP; Caprara ALF Medicines (Basel); 2023 May; 10(6):. PubMed ID: 37367728 [TBL] [Abstract][Full Text] [Related]
9. Phenytoin-associated movement disorder: A literature review. Rissardo JP; Caprara ALF Tzu Chi Med J; 2022; 34(4):409-417. PubMed ID: 36578637 [TBL] [Abstract][Full Text] [Related]
10. Valproate-associated Movement Disorder: A Literature Review. Rissardo JP; Caprara ALF; Durante Í Prague Med Rep; 2021; 122(3):140-180. PubMed ID: 34606429 [TBL] [Abstract][Full Text] [Related]
11. The adverse event profile of pregabalin across different disorders: a meta-analysis. Zaccara G; Perucca P; Gangemi PF Eur J Clin Pharmacol; 2012 Jun; 68(6):903-12. PubMed ID: 22271298 [TBL] [Abstract][Full Text] [Related]
12. Neurocysticercosis and movement disorders: A literature review. Rissardo JP; Caprara ALF; Durante Í Brain Circ; 2020; 6(4):225-241. PubMed ID: 33506145 [TBL] [Abstract][Full Text] [Related]
13. The Link Between Amitriptyline and Movement Disorders: Clinical Profile and Outcome. Rissardo JP; Caprara ALF Ann Acad Med Singap; 2020 Apr; 49(4):236-251. PubMed ID: 32419008 [TBL] [Abstract][Full Text] [Related]
14. Neurotoxic effects of pregabalin dependence on the brain frontal cortex in adult male albino rats. Elgazzar FM; Elseady WS; Hafez AS Neurotoxicology; 2021 Mar; 83():146-155. PubMed ID: 33515658 [TBL] [Abstract][Full Text] [Related]
15. Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health. Mańas A; Ciria JP; Fernández MC; Gonzálvez ML; Morillo V; Pérez M; Masramon X; López-Gómez V; Clin Transl Oncol; 2011 Sep; 13(9):656-63. PubMed ID: 21865137 [TBL] [Abstract][Full Text] [Related]
16. Preventive Analgesia with Pregabalin in Neuropathic Pain from “Failed Back Surgery Syndrome”: Assessment of Sleep Quality and Disability. Canos A; Cort L; Fernández Y; Rovira V; Pallarés J; Barberá M; Morales-Suárez-Varela M Pain Med; 2016 Feb; 17(2):344-52. PubMed ID: 26398133 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Gabapentin or pregabalin induced myoclonus: A case series and literature review. Desai A; Kherallah Y; Szabo C; Marawar R J Clin Neurosci; 2019 Mar; 61():225-234. PubMed ID: 30381161 [TBL] [Abstract][Full Text] [Related]
19. Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study. Lampl C; Schweiger C; Haider B; Lechner A J Neurol; 2010 Aug; 257(8):1265-73. PubMed ID: 20221770 [TBL] [Abstract][Full Text] [Related]
20. Effect of Gabapentin vs Pregabalin on Pain Intensity in Adults With Chronic Sciatica: A Randomized Clinical Trial. Robertson K; Marshman LAG; Plummer D; Downs E JAMA Neurol; 2019 Jan; 76(1):28-34. PubMed ID: 30326006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]